NCT00478114View on ClinicalTrials.gov

Efficacy and Safety of Sorafenib in Advanced Renal Cell Carcinoma (RCC)

PHASE3CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

March 31, 2010

Conditions
Renal Cell Carcinoma
Interventions
DRUG

sorafenib

sorafenib in the patients with advanced Renal Cell Carcinoma

Trial Locations (1)

10700

Siriraj Hospital, Department of Medicine, Bangkoknoi

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Mahidol University

OTHER

NCT00478114 - Efficacy and Safety of Sorafenib in Advanced Renal Cell Carcinoma (RCC) | Biotech Hunter | Biotech Hunter